<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.mcponline.org">
<title>Molecular &amp; Cellular Proteomics current issue</title>
<link>http://www.mcponline.org</link>
<description>Molecular &amp; Cellular Proteomics RSS feed -- current issue</description>
<prism:eIssn>1535-9484</prism:eIssn>
<prism:coverDisplayDate>Jul  1 2008 12:00:00:000AM</prism:coverDisplayDate>
<prism:publicationName>Molecular &amp; Cellular Proteomics</prism:publicationName>
<prism:issn>1535-9476</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1191?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1204?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1214?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1225?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1241?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1254?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1270?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1286?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1297?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1317?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1331?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1349?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1362?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1378?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1389?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1397?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1406?rss=1" />
  <rdf:li rdf:resource="http://www.mcponline.org/cgi/content/short/7/7/1408?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://www.mcponline.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://www.mcponline.org/icons/banner/title.gif">
<title>Molecular &amp; Cellular Proteomics</title>
<url>http://www.mcponline.org/icons/banner/title.gif</url>
<link>http://www.mcponline.org</link>
</image>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1191?rss=1">
<title><![CDATA[[Research] Quantitative Proteomics of a Presymptomatic A53T {alpha}-Synuclein Drosophila Model of Parkinson Disease]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1191?rss=1</link>
<description><![CDATA[
<P>A global isotopic labeling strategy combined with multidimensional liquid chromatographies and tandem mass spectrometry was used for quantitative proteome analysis of a presymptomatic A53T -synuclein <I>Drosophila</I> model of Parkinson disease (PD). Multiple internal standard proteins at different concentration ratios were spiked into samples from PD-like and control animals to assess quantification accuracy. Two biological replicates isotopically labeled in forward and reverse directions were analyzed. A total of 253 proteins were quantified with a minimum of two identified peptide sequences (for each protein); 180 (~71%) proteins were detected in both forward and reverse labeling measurements. Twenty-four proteins were differentially expressed in A53T -synuclein <I>Drosophila</I>; up-regulation of troponin T and down-regulation of fat body protein 1 were confirmed by Western blot analysis. Elevated expressions of heat shock protein 70 cognate 3 and ATP synthase are known to be directly involved in A53T -synuclein-mediated toxicity and PD; three up-regulated proteins (muscle LIM protein at 60A, manganese-superoxide dismutase, and troponin T) and two down-regulated proteins (chaoptin and retinal degeneration A) have literature-supported associations with cellular malfunctions. That these variations were observed in presymptomatic animals may shed light on the etiology of PD. Protein interaction network analysis indicated that seven proteins belong to a single network, which may provide insight into molecular pathways underlying PD. Gene Ontology analysis indicated that the dysregulated proteins are primarily associated with membrane, endoplasmic reticulum, actin cytoskeleton, mitochondria, and ribosome. These associations support prior findings in studies of the A30P -synuclein <I>Drosophila</I> model (Xun, Z. Y., Sowell, R. A., Kaufman, T. C., and Clemmer, D. E. (2007) Protein expression in a Drosophila model of Parkinson's disease. <I>J. Proteome Res.</I> 6, 348&ndash;357; Xun, Z. Y., Sowell, R. A., Kaufman, T. C., and Clemmer, D. E. (2007) Lifetime proteomic profiling of an A30P -synuclein <I>Drosophila</I> model of Parkinson's disease. <I>J. Proteome Res.</I> 6, 3729&ndash;3738) that defects in cellular components such as actin cytoskeleton and mitochondria may contribute to the development of later symptoms.</P>
]]></description>
<dc:creator><![CDATA[Xun, Z., Sowell, R. A., Kaufman, T. C., Clemmer, D. E.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:identifier>info:doi/10.1074/mcp.M700467-MCP200</dc:identifier>
<dc:title><![CDATA[[Research] Quantitative Proteomics of a Presymptomatic A53T {alpha}-Synuclein Drosophila Model of Parkinson Disease]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1203</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1191</prism:startingPage>
<prism:section>Research</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1204?rss=1">
<title><![CDATA[[Research] Increased {alpha}-Defensins as a Blood Marker for Schizophrenia Susceptibility]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1204?rss=1</link>
<description><![CDATA[
<P>Schizophrenia is a severe psychotic illness affecting 1% of the general population. There are no consistent pathological features, and the disorder is defined by a complex symptomatology, which overlaps with other psychiatric illnesses. Diagnosis is based on a clinical interview, relying on the patient meeting criteria according to diagnosis manuals, including <I>Diagnostic and Statistical Manual of Mental Disorders</I>, 4th Ed. and <I>International Statistical Classification of Diseases</I>, 10th Revision. Because of the ambiguous symptoms, the diagnostic process can take many months and often years. Rapid and effective treatment has been shown to impact positively on disease progression and outcome, and it is therefore important to identify disease-associated biomarkers allowing early diagnosis. Reliable biomarkers can be used for the development of diagnostic tests and may also help us understand the underlying pathology of this disorder. In the present study, proteins from anti-CD3 stimulated and unstimulated peripheral blood T cell lysates from 15 minimally medicated and unmedicated patients and 15 age-, sex-, race-, and smoking-matched controls were profiled on cation exchange (CM10) chips using SELDI-TOF. Partial least squares discriminate analysis was used to separate patient and control groups according to the expression of 108 detected peaks, and two peaks of 3,374 and 3,450 Da, corresponding to -defensins based on masses and cationic properties, were found to contribute significantly to the separation of patient and control groups. Reduction of T cell lysates with DTT resulted in a 6-Da shift in the mass of these peaks consistent with the presence of three cysteine bonds in the structure, confirming them as -defensins. Quantification of -defensins in T cell lysates from six patients and 18 healthy controls was carried out by ELISA, which also showed that -defensin levels were significantly increased in patient lysates when compared with matched controls (<I>p</I> = 0.0197). Plasma from 21 monozygotic twins discordant for schizophrenia and eight healthy unaffected twin pairs was also analyzed for the expression of -defensins by ELISA. Notably both affected and unaffected twins were found to have significantly elevated -defensin levels compared with healthy control twin pairs (<I>p</I> = 0.0014 and <I>p</I> = 0.0115, respectively). Increased expression of -defensins in unaffected as well as affected discordant monozygotic twins is of particular interest as monozygotic twins share genes and usually environmental upbringing. The unaffected twin therefore represents the biological and environmental risk of developing schizophrenia in the absence of overt symptomatology and therapeutic medication. These findings suggest that -defensins could be an important early indicator of the risk of schizophrenia.</P>
]]></description>
<dc:creator><![CDATA[Craddock, R. M., Huang, J. T., Jackson, E., Harris, N., Torrey, E. F., Herberth, M., Bahn, S.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:identifier>info:doi/10.1074/mcp.M700459-MCP200</dc:identifier>
<dc:title><![CDATA[[Research] Increased {alpha}-Defensins as a Blood Marker for Schizophrenia Susceptibility]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1213</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1204</prism:startingPage>
<prism:section>Research</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1214?rss=1">
<title><![CDATA[[Research] Alternative Splicing in Colon, Bladder, and Prostate Cancer Identified by Exon Array Analysis]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1214?rss=1</link>
<description><![CDATA[
<P>Alternative splicing enhances proteome diversity and modulates cancer-associated proteins. To identify tissue- and tumor-specific alternative splicing, we used the GeneChip Human Exon 1.0 ST Array to measure whole-genome exon expression in 102 normal and cancer tissue samples of different stages from colon, urinary bladder, and prostate. We identified 2069 candidate alternative splicing events between normal tissue samples from colon, bladder, and prostate and selected 15 splicing events for RT-PCR validation, 10 of which were successfully validated by RT-PCR and sequencing. Furthermore 23, 19, and 18 candidate tumor-specific splicing alterations in colon, bladder, and prostate, respectively, were selected for RT-PCR validation on an independent set of 81 normal and tumor tissue samples. In total, seven genes with tumor-specific splice variants were identified (<I>ACTN1</I>, <I>CALD1</I>, <I>COL6A3</I>, <I>LRRFIP2</I>, <I>PIK4CB</I>, <I>TPM1</I>, and <I>VCL</I>). The validated tumor-specific splicing alterations were highly consistent, enabling clear separation of normal and cancer samples and in some cases even of different tumor stages. A subset of the tumor-specific splicing alterations (<I>ACTN1</I>, <I>CALD1</I>, and <I>VCL</I>) was found in all three organs and may represent general cancer-related splicing events. <I>In silico</I> protein predictions suggest that the identified cancer-specific splice variants encode proteins with potentially altered functions, indicating that they may be involved in pathogenesis and hence represent novel therapeutic targets. In conclusion, we identified and validated alternative splicing between normal tissue samples from colon, bladder, and prostate in addition to cancer-specific splicing events in colon, bladder, and prostate cancer that may have diagnostic and prognostic implications.</P>
]]></description>
<dc:creator><![CDATA[Thorsen, K., Sorensen, K. D., Brems-Eskildsen, A. S., Modin, C., Gaustadnes, M., Hein, A.-M. K., Kruhoffer, M., Laurberg, S., Borre, M., Wang, K., Brunak, S., Krainer, A. R., Torring, N., Dyrskjot, L., Andersen, C. L., Orntoft, T. F.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:identifier>info:doi/10.1074/mcp.M700590-MCP200</dc:identifier>
<dc:title><![CDATA[[Research] Alternative Splicing in Colon, Bladder, and Prostate Cancer Identified by Exon Array Analysis]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1224</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1214</prism:startingPage>
<prism:section>Research</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1225?rss=1">
<title><![CDATA[[Research] A Combined Proteome and Ultrastructural Localization Analysis of 14-3-3 Proteins in Transformed Human Amnion (AMA) Cells: Definition of A Framework to Study Isoform-Specific Differences]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1225?rss=1</link>
<description><![CDATA[
<P>The 14-3-3 proteins constitute a family of highly conserved and broadly expressed multifunctional polypeptides that are involved in a variety of important cellular processes that include cell cycle progression, growth, differentiation, and apoptosis. Although the exact cellular function(s) of 14-3-3 proteins is not fully elucidated, as a rule these proteins act by binding to protein ligands, thus regulating their activity; so far more than 300 cellular proteins have been reported to interact with 14-3-3 proteins. Binding to cognate interacting partners is isoform-specific, but redundancy also exists as several binding peptides can be recognized by all isoforms, and some functions can be carried out by any isoform indistinctly. Moreover by interacting with different ligands in a spatially and temporally regulated fashion the same isoform can play multiple possibly even opposing roles where the resultant cellular outcome will be determined by the integration of the various effects. Although there is a large body of literature on specific aspects of 14-3-3 biology, not much is known on the coordinated aspects of 14-3-3 isoform expression, post-translational modifications, and subcellular localization. To address the question of isoform-specific differences, we carried out a comparative analysis of the patterns of expression, phosphorylation, and subcellular localization of the 14-3-3 &beta;, , , , and  protein isoforms in transformed human amnion (AMA) cells. To validate as well as broaden our observations we analyzed the occurrence of the various isoforms in a large number of established cell lines and mammary and urothelial tissue specimens. Given the systematic approach we undertook and our application of isoform-discriminating technologies to the analysis of various cellular systems, we expect the data presented in this study to serve as an enabling resource for researchers working with 14-3-3 proteins.</P>
]]></description>
<dc:creator><![CDATA[Moreira, J. M. A., Shen, T., Ohlsson, G., Gromov, P., Gromova, I., Celis, J. E.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:identifier>info:doi/10.1074/mcp.M700439-MCP200</dc:identifier>
<dc:title><![CDATA[[Research] A Combined Proteome and Ultrastructural Localization Analysis of 14-3-3 Proteins in Transformed Human Amnion (AMA) Cells: Definition of A Framework to Study Isoform-Specific Differences]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1240</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1225</prism:startingPage>
<prism:section>Research</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1241?rss=1">
<title><![CDATA[[Research] In-cell Selectivity Profiling of Serine Protease Inhibitors by Activity-based Proteomics]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1241?rss=1</link>
<description><![CDATA[
<P>Activity-based proteomics is a methodology that is used to quantify the catalytically active subfraction of enzymes present in complex mixtures such as lysates or living cells. To apply this approach for in-cell selectivity profiling of inhibitors of serine proteases, we designed a novel activity-based probe (ABP). This ABP consists of (i) a fluorophosphonate-reactive group, directing the probe toward serine hydrolases or proteases and (ii) an alkyne functionality that can be specifically detected at a later stage with an azide-functionalized reporter group through a Cu(I)-catalyzed coupling reaction ("click chemistry"). This novel ABP was shown to label the active site of several serine proteases with greater efficiency than a previously reported fluorophosphonate probe. More importantly, our probe was cell-permeable and achieved labeling of enzymes within living cells with efficiency similar to that observed for the corresponding lysate fraction. Several endogenous serine hydrolases whose activities were detected upon in-cell labeling were identified by two-dimensional gel and MS analyses. As a proof of principle, cell-permeable inhibitors of an endogenous serine protease (prolyl endopeptidase) were assessed for their potency and specificity in competing for the <I>in situ</I> labeling of the selected enzyme. Altogether these results open new perspectives for safety profiling studies in uncovering potential cellular "side effects" of drugs (unanticipated off-target inhibition or activation) that may be overlooked by standard selectivity profiling methods.</P>
]]></description>
<dc:creator><![CDATA[Gillet, L. C. J., Namoto, K., Ruchti, A., Hoving, S., Boesch, D., Inverardi, B., Mueller, D., Coulot, M., Schindler, P., Schweigler, P., Bernardi, A., Gil-Parrado, S.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:identifier>info:doi/10.1074/mcp.M700505-MCP200</dc:identifier>
<dc:title><![CDATA[[Research] In-cell Selectivity Profiling of Serine Protease Inhibitors by Activity-based Proteomics]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1253</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1241</prism:startingPage>
<prism:section>Research</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1254?rss=1">
<title><![CDATA[[Research] Evolutionary and Transcriptional Analysis of Karyopherin {beta} Superfamily Proteins ]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1254?rss=1</link>
<description><![CDATA[
<P>In eukaryotes, karyopherin &beta; superfamily proteins mediate nucleocytoplasmic transport of macromolecules. We investigated the evolutionary and transcriptional patterns of these proteins using bioinformatics approaches. No obvious homologs were found in prokaryotes, but an extensive set of &beta;-karyopherin proteins was found in yeast. Among 14 &beta;-karyopherins of <I>Saccharomyces cerevisiae</I>, eight corresponded to their human orthologs directly without diversification, two were lost, and the remaining four proteins exhibited gene duplications by different mechanisms. We also identified &beta;-karyopherin orthologs in <I>Caenorhabditis elegans</I>, <I>Drosophila melanogaster</I>, <I>Danio rerio</I>, <I>Xenopus tropicalis</I>, <I>Gallus gallus</I>, and <I>Mus musculus</I>. &beta;-Karyopherins were ubiquitously but nonuniformly expressed in distinct cells and tissues. In yeast and mice, the titer of some &beta;-karyopherin transcripts appeared to be regulated both during the cell cycle and during development. Further virtual analysis of promoter binding elements suggested that the transcription factors SP1, NRF-2, HEN-1, RREB-1, and nuclear factor Y regulate expression of most &beta;-karyopherin genes. These findings emphasize new mechanisms in functional diversification of &beta;-karyopherins and regulation of nucleocytoplasmic transport.</P>
]]></description>
<dc:creator><![CDATA[Quan, Y., Ji, Z.-L., Wang, X., Tartakoff, A. M., Tao, T.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:identifier>info:doi/10.1074/mcp.M700511-MCP200</dc:identifier>
<dc:title><![CDATA[[Research] Evolutionary and Transcriptional Analysis of Karyopherin {beta} Superfamily Proteins ]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1269</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1254</prism:startingPage>
<prism:section>Research</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1270?rss=1">
<title><![CDATA[[Research] Proteomics Analysis Identifies Molecular Targets Related to Diabetes Mellitus-associated Bladder Dysfunction ]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1270?rss=1</link>
<description><![CDATA[
<P>Protein expression profiles in rat bladder smooth muscle were compared between animal models of streptozotocin-induced diabetes mellitus (STZ-DM) and age-matched controls at 1 week and 2 months after induction of hyperglycemia with STZ treatment. At each time point, protein samples from four STZ-DM and four age-matched control rat bladder tissues were prepared independently and analyzed together across multiple DIGE gels using a pooled internal standard sample to quantify expression changes with statistical confidence. A total of 100 spots were determined to be significantly changing among the four experimental groups. A subsequent mass spectrometry analysis of the 100 spots identified a total of 56 unique proteins. Of the proteins identified by two-dimensional DIGE/MS, 10 exhibited significant changes 1 week after STZ-induced hyperglycemia, whereas the rest showed differential expression after 2 months. A network analysis of these proteins using MetaCore<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP> suggested induction of transcriptional factors that are too low to be detected by two-dimensional DIGE and identified an enriched cluster of down-regulated proteins that are involved in cell adhesion, cell shape control, and motility, including vinculin, intermediate filaments, Ppp2r1a, and extracellular matrix proteins. The proteins that were up-regulated include proteins involved in muscle contraction (<I>e.g.</I> Mrlcb and Ly-GDI), in glycolysis (<I>e.g.</I> -enolase and Taldo1), in mRNA processing (<I>e.g.</I> heterogeneous nuclear ribonucleoprotein A2/B1), in inflammatory response (<I>e.g.</I> S100A9, Annexin 1, and apoA-I), and in chromosome segregation and migration (<I>e.g.</I> Tuba1 and Vil2). Our results suggest that the development of diabetes-related complications in this model involves the down-regulation of structural and extracellular matrix proteins in smooth muscle that are essential for normal muscle contraction and relaxation but also induces proteins that are associated with cell proliferation and inflammation that may account for some of the functional deficits known to occur in diabetic complications of bladder.</P>
]]></description>
<dc:creator><![CDATA[Yohannes, E., Chang, J., Christ, G. J., Davies, K. P., Chance, M. R.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:identifier>info:doi/10.1074/mcp.M700563-MCP200</dc:identifier>
<dc:title><![CDATA[[Research] Proteomics Analysis Identifies Molecular Targets Related to Diabetes Mellitus-associated Bladder Dysfunction ]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1285</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1270</prism:startingPage>
<prism:section>Research</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1286?rss=1">
<title><![CDATA[[Research] Trypanosoma brucei Mitochondrial Ribosomes: Affinity Purification and Component Identification by Mass Spectrometry]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1286?rss=1</link>
<description><![CDATA[
<P>Although eukaryotic mitochondrial (mt) ribosomes evolved from a putative prokaryotic ancestor their compositions vary considerably among organisms. We determined the protein composition of tandem affinity-purified <I>Trypanosoma brucei</I> mt ribosomes by mass spectrometry and identified 133 proteins of which 77 were associated with the large subunit and 56 were associated with the small subunit. Comparisons with bacterial and mammalian mt ribosomal proteins identified <I>T. brucei</I> mt homologs of L2&ndash;4, L7/12, L9, L11, L13&ndash;17, L20&ndash;24, L27&ndash;30, L33, L38, L43, L46, L47, L49, L52, S5, S6, S8, S9, S11, S15&ndash;18, S29, and S34, although the degree of conservation varied widely. Sequence characteristics of some of the component proteins indicated apparent functions in rRNA modification and processing, protein assembly, and mitochondrial metabolism implying possible additional roles for these proteins. Nevertheless most of the identified proteins have no homology outside Kinetoplastida implying very low conservation and/or a divergent function in kinetoplastid mitochondria.</P>
]]></description>
<dc:creator><![CDATA[Zikova, A., Panigrahi, A. K., Dalley, R. A., Acestor, N., Anupama, A., Ogata, Y., Myler, P. J., Stuart, K.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:identifier>info:doi/10.1074/mcp.M700490-MCP200</dc:identifier>
<dc:title><![CDATA[[Research] Trypanosoma brucei Mitochondrial Ribosomes: Affinity Purification and Component Identification by Mass Spectrometry]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1296</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1286</prism:startingPage>
<prism:section>Research</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1297?rss=1">
<title><![CDATA[[Research] Heterogeneity of the Mitochondrial Proteome for Photosynthetic and Non-photosynthetic Arabidopsis Metabolism]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1297?rss=1</link>
<description><![CDATA[
<P>Heterogeneity of the mitochondrial proteome in plants underlies fundamental differences in the roles of these organelles in different tissues. We quantitatively compared the mitochondrial proteome isolated from a non-photosynthetic cell culture model with more specialized mitochondria isolated from photosynthetic shoots. Differences in intact mitochondrial respiratory rates with various substrates and activities of specific enzymes provided a backdrop of the functional variation between these mitochondrial populations. Proteomics comparisons provided a deep insight into the different steady-state abundances of specific mitochondrial proteins. Combined these data showed the elevated level of the photorespiratory apparatus and its complex interplay with glycolate, cysteine, formate, and one-carbon metabolism as well as the decrease of selected parts of the tricarboxylic acid cycle, alterations in amino acid metabolism focused on 2-oxoglutarate generation, and degradation of branched chain amino acids. Comparisons with microarray analysis of these tissue types showed a positive, mild correlation between mRNA and mitochondrial protein abundance, a tighter correlation for specific biochemical pathways, but over 78% concordance in direction between changes in protein and transcript abundance in the two tissues. Overall these results indicated that the majority of the variation in the plant mitochondrial proteome occurred in the matrix, highlighted the constitutive nature of the respiratory apparatus, and showed the differences in substrate choice and/or availability during photosynthetic and non-photosynthetic metabolism.</P>
]]></description>
<dc:creator><![CDATA[Lee, C. P., Eubel, H., O'Toole, N., Millar, A. H.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:identifier>info:doi/10.1074/mcp.M700535-MCP200</dc:identifier>
<dc:title><![CDATA[[Research] Heterogeneity of the Mitochondrial Proteome for Photosynthetic and Non-photosynthetic Arabidopsis Metabolism]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1316</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1297</prism:startingPage>
<prism:section>Research</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1317?rss=1">
<title><![CDATA[[Research] Deep Coverage Mouse Red Blood Cell Proteome: A First Comparison with the Human Red Blood Cell]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1317?rss=1</link>
<description><![CDATA[
<P>Mice have close genetic/physiological relationships to humans, breed rapidly, and can be genetically modified, making them the most used mammal in biomedical research. Because the red blood cell (RBC) is the sole gas transporter in vertebrates, diseases of the RBC are frequently severe; much research has therefore focused on RBC and cardiovascular disorders of mouse and humans. RBCs also host malaria parasites. Recently we presented an in-depth proteome for the human RBC. Here we present directly comparable data for the mouse RBC as membrane-only, soluble-only, and combined membrane-bound/soluble proteomes (comprising, respectively, 247, 232, and 165 proteins). All proteins were identified, validated, and categorized in terms of subcellular localization, protein family, and function, and in comparison with the human RBC, were classified as orthologs, family-related, or unique. Splice isoforms were identified, and polypeptides migrating with anomalous apparent molecular weights were grouped into putatively ubiquitinated or partially degraded complexes. Overall there was close concordance between mouse and human proteomes, confirming the unexpected RBC complexity. Several novel findings in the human proteome have been confirmed here. This comparison sheds light on several open issues in RBC biology and provides a departure point for more comprehensive understanding of RBC function.</P>
]]></description>
<dc:creator><![CDATA[Pasini, E. M., Kirkegaard, M., Salerno, D., Mortensen, P., Mann, M., Thomas, A. W.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:identifier>info:doi/10.1074/mcp.M700458-MCP200</dc:identifier>
<dc:title><![CDATA[[Research] Deep Coverage Mouse Red Blood Cell Proteome: A First Comparison with the Human Red Blood Cell]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1330</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1317</prism:startingPage>
<prism:section>Research</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1331?rss=1">
<title><![CDATA[[Research] Phosphoproteomic Analysis of the Mouse Brain Cytosol Reveals a Predominance of Protein Phosphorylation in Regions of Intrinsic Sequence Disorder]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1331?rss=1</link>
<description><![CDATA[
<P>We analyzed the mouse forebrain cytosolic phosphoproteome using sequential (protein and peptide) IMAC purifications, enzymatic dephosphorylation, and targeted tandem mass spectrometry analysis strategies. In total, using complementary phosphoenrichment and LC-MS/MS strategies, 512 phosphorylation sites on 540 non-redundant phosphopeptides from 162 cytosolic phosphoproteins were characterized. Analysis of protein domains and amino acid sequence composition of this data set of cytosolic phosphoproteins revealed that it is significantly enriched in intrinsic sequence disorder, and this enrichment is associated with both cellular location and phosphorylation status. The majority of phosphorylation sites found by MS were located outside of structural protein domains (97%) but were mostly located in regions of intrinsic sequence disorder (86%). 368 phosphorylation sites were located in long regions of disorder (over 40 amino acids long), and 94% of proteins contained at least one such long region of disorder. In addition, we found that 58 phosphorylation sites in this data set occur in 14-3-3 binding consensus motifs, linear motifs that are associated with unstructured regions in proteins. These results demonstrate that in this data set protein phosphorylation is significantly depleted in protein domains and significantly enriched in disordered protein sequences and that enrichment of intrinsic sequence disorder may be a common feature of phosphoproteomes. This supports the hypothesis that disordered regions in proteins allow kinases, phosphatases, and phosphorylation-dependent binding proteins to gain access to target sequences to regulate local protein conformation and activity.</P>
]]></description>
<dc:creator><![CDATA[Collins, M. O., Yu, L., Campuzano, I., Grant, S. G. N., Choudhary, J. S.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:identifier>info:doi/10.1074/mcp.M700564-MCP200</dc:identifier>
<dc:title><![CDATA[[Research] Phosphoproteomic Analysis of the Mouse Brain Cytosol Reveals a Predominance of Protein Phosphorylation in Regions of Intrinsic Sequence Disorder]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1348</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1331</prism:startingPage>
<prism:section>Research</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1349?rss=1">
<title><![CDATA[[Research] Identification of Paracrine Neuroprotective Candidate Proteins by a Functional Assay-driven Proteomics Approach]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1349?rss=1</link>
<description><![CDATA[
<P>Glial cells support neuronal survival and function by secreting neurotrophic cytokines. Retinal Mueller glial cells (RMGs) support retinal neurons, especially photoreceptors. These highly light-sensitive sensory neurons receive vision, and their death results in blinding diseases. It has been proposed that RMGs release factors that support photoreceptor survival, but the nature of these factors remains to be elucidated. To discover such neurotrophic factors, we developed an integrated work flow toward systematic identification of neuroprotective proteins, which are, like most cytokines, expressed only in minute amounts. This strategy can be generally applied to identify secreted bioactive molecules from any body fluid once a recipient cell for this activity is known. Toward this goal we first isolated conditioned medium (CM) from primary porcine RMGs cultured <I>in vitro</I> and tested for survival-promoting activity using primary photoreceptors. We then developed a large scale, microplate-based cellular high content assay that allows rapid assessment of primary photoreceptor survival concomitant with biological activity <I>in vitro</I>. The enrichment strategy of bioactive proteins toward their identification consists of several fractionation steps combined with tests for biological function. Here we combined 1) size fractionation, 2) ion exchange chromatography, 3) reverse phase liquid chromatography, and 4) mass spectrometry (Q-TOF MS/MS or MALDI MS/MS) for protein identification. As a result of this integrated work flow, the insulin-like growth factor-binding proteins IGFBP5 and IGFBP7 and connective tissue growth factor (CTGF) were identified as likely candidates. Cloning and stable expression of these three candidate factors in HEK293 cells produced conditioned medium enriched for either one of the factors. IGFBP5 and CTGF, but not IGFBP7, significantly increased photoreceptor survival when secreted from HEK293 cells and when added to the original RMG-CM. This indicates that the survival-promoting activity in RMG-CM is multifactorial with IGFBP5 and CTGF as an integral part of this activity.</P>
]]></description>
<dc:creator><![CDATA[Hauck, S. M., Gloeckner, C. J., Harley, M. E., Schoeffmann, S., Boldt, K., Ekstrom, P. A. R., Ueffing, M.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:identifier>info:doi/10.1074/mcp.M700456-MCP200</dc:identifier>
<dc:title><![CDATA[[Research] Identification of Paracrine Neuroprotective Candidate Proteins by a Functional Assay-driven Proteomics Approach]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1361</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1349</prism:startingPage>
<prism:section>Research</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1362?rss=1">
<title><![CDATA[[Research] Monitoring Protein-Protein Interactions between the Mammalian Integral Membrane Transporters and PDZ-interacting Partners Using a Modified Split-ubiquitin Membrane Yeast Two-hybrid System]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1362?rss=1</link>
<description><![CDATA[
<P>PDZ-binding motifs are found in the C-terminal tails of numerous integral membrane proteins where they mediate specific protein-protein interactions by binding to PDZ-containing proteins. Conventional yeast two-hybrid screens have been used to probe protein-protein interactions of these soluble C termini. However, to date no <I>in vivo</I> technology has been available to study interactions between the full-length integral membrane proteins and their cognate PDZ-interacting partners. We previously developed a split-ubiquitin membrane yeast two-hybrid (MYTH) system to test interactions between such integral membrane proteins by using a transcriptional output based on cleavage of a transcription factor from the C terminus of membrane-inserted baits. Here we modified MYTH to permit detection of C-terminal PDZ domain interactions by redirecting the transcription factor moiety from the C to the N terminus of a given integral membrane protein thus liberating their native C termini. We successfully applied this "MYTH 2.0" system to five different mammalian full-length renal transporters and identified novel PDZ domain-containing partners of the phosphate (NaPi-IIa) and sulfate (NaS1) transporters that would have otherwise not been detectable. Furthermore this assay was applied to locate the PDZ-binding domain on the NaS1 protein. We showed that the PDZ-binding domain for PDZK1 on NaS1 is upstream of its C terminus, whereas the two interacting proteins, NHERF-1 and NHERF-2, bind at a location closer to the N terminus of NaS1. Moreover NHERF-1 and NHERF-2 increased functional sulfate uptake in <I>Xenopus</I> oocytes when co-expressed with NaS1. Finally we used MYTH 2.0 to demonstrate that the NaPi-IIa transporter homodimerizes via protein-protein interactions within the lipid bilayer. In summary, our study establishes the MYTH 2.0 system as a novel tool for interactive proteomics studies of membrane protein complexes.</P>
]]></description>
<dc:creator><![CDATA[Gisler, S. M., Kittanakom, S., Fuster, D., Wong, V., Bertic, M., Radanovic, T., Hall, R. A., Murer, H., Biber, J., Markovich, D., Moe, O. W., Stagljar, I.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:identifier>info:doi/10.1074/mcp.M800079-MCP200</dc:identifier>
<dc:title><![CDATA[[Research] Monitoring Protein-Protein Interactions between the Mammalian Integral Membrane Transporters and PDZ-interacting Partners Using a Modified Split-ubiquitin Membrane Yeast Two-hybrid System]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1377</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1362</prism:startingPage>
<prism:section>Research</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1378?rss=1">
<title><![CDATA[[Research] Identification of CKAP4/p63 as a Major Substrate of the Palmitoyl Acyltransferase DHHC2, a Putative Tumor Suppressor, Using a Novel Proteomics Method]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1378?rss=1</link>
<description><![CDATA[
<P>Protein palmitoylation is the post-translational addition of the 16-carbon fatty acid palmitate to specific cysteine residues by a labile thioester linkage. Palmitoylation is mediated by a family of at least 23 palmitoyl acyltransferases (PATs) characterized by an Asp-His-His-Cys (DHHC) motif. Many palmitoylated proteins have been identified, but PAT-substrate relationships are mostly unknown. Here we present a method called palmitoyl-cysteine isolation capture and analysis (or PICA) to identify PAT-substrate relationships in a living vertebrate system and demonstrate its effectiveness by identifying CKAP4/p63 as a substrate of DHHC2, a putative tumor suppressor.</P>
]]></description>
<dc:creator><![CDATA[Zhang, J., Planey, S. L., Ceballos, C., Stevens, S. M., Keay, S. K., Zacharias, D. A.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:identifier>info:doi/10.1074/mcp.M800069-MCP200</dc:identifier>
<dc:title><![CDATA[[Research] Identification of CKAP4/p63 as a Major Substrate of the Palmitoyl Acyltransferase DHHC2, a Putative Tumor Suppressor, Using a Novel Proteomics Method]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1388</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1378</prism:startingPage>
<prism:section>Research</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1389?rss=1">
<title><![CDATA[[Research] A Multidimensional Chromatography Technology for In-depth Phosphoproteome Analysis]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1389?rss=1</link>
<description><![CDATA[
<P>Protein phosphorylation is a post-translational modification widely used to regulate cellular responses. Recent studies showed that global phosphorylation analysis could be used to study signaling pathways and to identify targets of protein kinases in cells. A key objective of global phosphorylation analysis is to obtain an in-depth mapping of low abundance protein phosphorylation in cells; this necessitates the use of suitable separation techniques because of the complexity of the phosphoproteome. Here we developed a multidimensional chromatography technology, combining IMAC, hydrophilic interaction chromatography, and reverse phase LC, for phosphopeptide purification and fractionation. Its application to the yeast <I>Saccharomyces cerevisiae</I> after DNA damage led to the identification of 8764 unique phosphopeptides from 2278 phosphoproteins using tandem MS. Analysis of two low abundance proteins, Rad9 and Mrc1, revealed that ~50% of their phosphorylation was identified via this global phosphorylation analysis. Thus, this technology is suited for in-depth phosphoproteome studies.</P>
]]></description>
<dc:creator><![CDATA[Albuquerque, C. P., Smolka, M. B., Payne, S. H., Bafna, V., Eng, J., Zhou, H.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:identifier>info:doi/10.1074/mcp.M700468-MCP200</dc:identifier>
<dc:title><![CDATA[[Research] A Multidimensional Chromatography Technology for In-depth Phosphoproteome Analysis]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1396</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1389</prism:startingPage>
<prism:section>Research</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1397?rss=1">
<title><![CDATA[[Research] Retinal Pigment Epithelium Lipofuscin Proteomics]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1397?rss=1</link>
<description><![CDATA[
<P>Lipofuscin accumulates with age in the retinal pigment epithelium (RPE) in discrete granular organelles and may contribute to age-related macular degeneration. Because previous studies suggest that lipofuscin contains protein that may impact pathogenic mechanisms, we pursued proteomics analysis of lipofuscin. The composition of RPE lipofuscin and its mechanisms of pathogenesis are poorly understood in part because of the heterogeneity of isolated preparations. We purified RPE lipofuscin granules by treatment with proteinase K or SDS and showed by light, confocal, and transmission electron microscopy that the purified granules are free of extragranular material and associated membranes. Crude and purified lipofuscin preparations were quantitatively compared by (i) LC MS/MS proteomics analyses, (ii) immunoanalyses of oxidative protein modifications, (iii) amino acid analysis, (iv) HPLC of bisretinoids, and (v) assaying phototoxicity to RPE cells. From crude lipofuscin preparations 186 proteins were identified, many of which appeared to be modified. In contrast, very little protein (~2% (w/w) by amino acid analysis) and no identifiable protein were found in the purified granules, which retained full phototoxicity to cultured RPE cells. Our analyses showed that granules in purified and crude lipofuscin preparations exhibit no statistically significant differences in diameter or circularity or in the content of the bisretinoids A2E, isoA2E, and all-<I>trans</I>-retinal dimer-phosphatidylethanolamine. The finding that the purified granules contain minimal protein yet retain phototoxic activity suggests that RPE lipofuscin pathogenesis is largely independent of associated protein. The purified granules also exhibited oxidative protein modifications, including nitrotyrosine generated from reactive nitrogen oxide species and carboxyethylpyrrole and iso[4]levuglandin E<SUB>2</SUB> adducts generated from reactive lipid fragments. This finding is consistent with previous studies demonstrating RPE lipofuscin to be a potent generator of reactive oxygen species and supports the hypothesis that such species, including reactive fragments from lipids and retinoids, contribute to the mechanisms of RPE lipofuscin pathogenesis.</P>
]]></description>
<dc:creator><![CDATA[Ng, K.-P., Gugiu, B., Renganathan, K., Davies, M. W., Gu, X., Crabb, J. S., Kim, S. R., Rozanowska, M. B., Bonilha, V. L., Rayborn, M. E., Salomon, R. G., Sparrow, J. R., Boulton, M. E., Hollyfield, J. G., Crabb, J. W.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:identifier>info:doi/10.1074/mcp.M700525-MCP200</dc:identifier>
<dc:title><![CDATA[[Research] Retinal Pigment Epithelium Lipofuscin Proteomics]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1405</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1397</prism:startingPage>
<prism:section>Research</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1406?rss=1">
<title><![CDATA[[HUPO Views] Proteomics in India: An Overview]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1406?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Sirdeshmukh, R.]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:title><![CDATA[[HUPO Views] Proteomics in India: An Overview]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1407</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1406</prism:startingPage>
<prism:section>HUPO Views</prism:section>
</item>

<item rdf:about="http://www.mcponline.org/cgi/content/short/7/7/1408?rss=1">
<title><![CDATA[[Information] Calendar]]></title>
<link>http://www.mcponline.org/cgi/content/short/7/7/1408?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-06-30</dc:date>
<dc:title><![CDATA[[Information] Calendar]]></dc:title>
<dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
<prism:number>7</prism:number>
<prism:volume>7</prism:volume>
<prism:endingPage>1408</prism:endingPage>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:startingPage>1408</prism:startingPage>
<prism:section>Information</prism:section>
</item>

</rdf:RDF>